Log in

NASDAQ:PLSE - Pulse Biosciences Stock Price, Forecast & News

$6.68
+0.32 (+5.03 %)
(As of 03/29/2020 02:08 AM ET)
Today's Range
$6.04
Now: $6.68
$6.85
50-Day Range
$5.23
MA: $7.96
$13.75
52-Week Range
$5.11
Now: $6.68
$17.96
Volume71,967 shs
Average Volume108,748 shs
Market Capitalization$139.14 million
P/E RatioN/A
Dividend YieldN/A
Beta2.41
Pulse Biosciences, Inc. operates as a clinical stage medical therapy company. It engages in the research and development, and commercialization of CellFX system that provides a precise and non-thermal cellular treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing surrounding non-cellular tissue primarily for dermatology applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.
Read More
Pulse Biosciences logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PLSE
CUSIPN/A
Phone510-906-4600

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$1.48 per share

Profitability

Net Income$-46,970,000.00

Miscellaneous

Employees54
Market Cap$139.14 million
Next Earnings Date5/5/2020 (Estimated)
OptionableOptionable

Receive PLSE News and Ratings via Email

Sign-up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter.


Pulse Biosciences (NASDAQ:PLSE) Frequently Asked Questions

How has Pulse Biosciences' stock been impacted by COVID-19 (Coronavirus)?

Pulse Biosciences' stock was trading at $6.36 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PLSE stock has increased by 5.0% and is now trading at $6.68. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Pulse Biosciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pulse Biosciences in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Pulse Biosciences.

When is Pulse Biosciences' next earnings date?

Pulse Biosciences is scheduled to release its next quarterly earnings announcement on Tuesday, May 5th 2020. View our earnings forecast for Pulse Biosciences.

How were Pulse Biosciences' earnings last quarter?

Pulse Biosciences Inc (NASDAQ:PLSE) announced its quarterly earnings results on Monday, March, 16th. The company reported ($0.66) EPS for the quarter, missing analysts' consensus estimates of ($0.61) by $0.05. View Pulse Biosciences' earnings history.

What price target have analysts set for PLSE?

1 Wall Street analysts have issued 12 month price targets for Pulse Biosciences' stock. Their forecasts range from $6.00 to $6.00. On average, they anticipate Pulse Biosciences' stock price to reach $6.00 in the next twelve months. This suggests that the stock has a possible downside of 10.2%. View analysts' price targets for Pulse Biosciences.

Has Pulse Biosciences been receiving favorable news coverage?

Media stories about PLSE stock have trended negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Pulse Biosciences earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutPulse Biosciences.

Are investors shorting Pulse Biosciences?

Pulse Biosciences saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 2,610,000 shares, an increase of 11.5% from the February 13th total of 2,340,000 shares. Based on an average daily trading volume, of 79,800 shares, the days-to-cover ratio is presently 32.7 days. Currently, 23.5% of the company's shares are sold short. View Pulse Biosciences' Current Options Chain.

Who are some of Pulse Biosciences' key competitors?

What other stocks do shareholders of Pulse Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pulse Biosciences investors own include Energous (WATT), Advanced Micro Devices (AMD), Bausch Health Companies (BHC), Wayfair (W), Achaogen (AKAO), AbbVie (ABBV), Fate Therapeutics (FATE), Portola Pharmaceuticals (PTLA), Roku (ROKU) and Exelixis (EXEL).

Who are Pulse Biosciences' key executives?

Pulse Biosciences' management team includes the following people:
  • Mr. Darrin R. Uecker, Pres, CEO & Director (Age 53)
  • Mr. Brian B. Dow, CFO, Sr. VP of Fin. & Admin., Treasurer and Sec. (Age 50)
  • Mr. Edward A. Ebbers, Exec. VP & GM of Dermatology (Age 59)
  • Dr. Richard Nuccitelli Ph.D., Chief Science Officer
  • Dr. Holly Hartman Ph.D., J.D., VP of Bus. Devel. & Corp. Strategy

When did Pulse Biosciences IPO?

(PLSE) raised $20 million in an IPO on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.

What is Pulse Biosciences' stock symbol?

Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."

Who are Pulse Biosciences' major shareholders?

Pulse Biosciences' stock is owned by many different institutional and retail investors. Top institutional investors include State Street Corp (0.92%), Geode Capital Management LLC (0.75%), Griffin Asset Management Inc. (0.24%), Bank of New York Mellon Corp (0.15%), UBS Group AG (0.07%) and Barclays PLC (0.05%). View institutional ownership trends for Pulse Biosciences.

Which major investors are selling Pulse Biosciences stock?

PLSE stock was sold by a variety of institutional investors in the last quarter, including Steward Partners Investment Advisory LLC. View insider buying and selling activity for Pulse Biosciences.

Which major investors are buying Pulse Biosciences stock?

PLSE stock was purchased by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, State Street Corp, Barclays PLC, Geode Capital Management LLC, Griffin Asset Management Inc., UBS Group AG, Bank of New York Mellon Corp, and Citigroup Inc.. View insider buying and selling activity for Pulse Biosciences.

How do I buy shares of Pulse Biosciences?

Shares of PLSE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Pulse Biosciences' stock price today?

One share of PLSE stock can currently be purchased for approximately $6.68.

How big of a company is Pulse Biosciences?

Pulse Biosciences has a market capitalization of $139.14 million. The company earns $-46,970,000.00 in net income (profit) each year or ($2.26) on an earnings per share basis. Pulse Biosciences employs 54 workers across the globe. View additional information about Pulse Biosciences.

What is Pulse Biosciences' official website?

The official website for Pulse Biosciences is http://www.pulsebiosciences.com/.

How can I contact Pulse Biosciences?

Pulse Biosciences' mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The company can be reached via phone at 510-906-4600 or via email at [email protected]


MarketBeat Community Rating for Pulse Biosciences (NASDAQ PLSE)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  225 (Vote Outperform)
Underperform Votes:  198 (Vote Underperform)
Total Votes:  423
MarketBeat's community ratings are surveys of what our community members think about Pulse Biosciences and other stocks. Vote "Outperform" if you believe PLSE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PLSE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Featured Article: Percentage Decliners

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel